相关实验视频
Updated: Jul 18, 2025

06:34
The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability
Published on: April 28, 2022
4.8K
心脏病综合征和补充铁的好处超过风险:一个叙述性回顾
Georgia Doumani1, Georgios Spanos2, Panagiotis Theofilis1
1Center for Nephrology "G. Papadakis", General Hospital of Nikaia, Piraeus "Agios Panteleimon", 18454, Piraeus, Nikaia, Greece.
International urology and nephrology
|August 22, 2023
概括
静脉注射铁疗法有利于患有心综合征 (CRS) 和铁缺乏症的患者,通过改善贫血,心力衰竭症状和潜在的功能. 这种治疗可以减少住院治疗,提高整体生活质量.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液学 血液学 血液学
背景情况:
- 心脏病综合征 (CRS) 涉及到心脏和脏之间的复杂相互作用.
- 铁缺乏症在心力衰竭 (HF) 和CRS患者中普遍存在,通常与贫血或不存在.
- 静脉注射铁在这些条件下越来越多地被认为是其治疗潜力.
研究的目的:
- 审查关于静脉注射铁治疗对CRS和铁缺乏症患者的影响的现有文献.
- 探索静脉注射铁对心脏和脏结果的影响.
- 突出改善患者生活质量和临床结果的潜在好处.
主要方法:
- 发表的研究的系统审查.
- 分析临床试验数据和观察性研究.
- 评估铁对贫血,HF症状,住院和功能标志物的影响.
主要成果:
- 静脉注射铁可以改善缺铁患者的贫血,HF症状和功能能力.
- 有证据表明,HF恶化的住院病例减少,生活质量改善.
- 新出现的数据表明,在CRS患者中,估计的膜过率和功能可能有所改善.
结论:
- 静脉注射铁疗法是一种有价值的干预措施,用于控制心综合征中的铁缺乏症.
- 它对CRS的心脏和脏方面都有好处,同时改善了患者报告的结果.
- 需要进一步的研究,以充分阐明其临床影响,并优化其在患者护理中的使用.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
Renal Failure: Dose Adjustments
121
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
121
Chronic Kidney Disease III: Interprofessional Care
42
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
42
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Acute Kidney Injury IV: Diagnostic Studies and Prevention
34
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
34
Cardiac Catheterization I: Pre-Procedure Overview
57
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
57

